Clinical Trial Update: A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics, pharmacodynamics, and safety of TA-7284 in adults with Type 2 diabetes mellitus and moderate renal impairment. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TA-7284

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2014-06-11